xmlns:atom="http://www.w3.org/2005/Atom"
174. The prohibitions in regulation 46 (requirement for authorisation) do not apply where the sale or supply of a medicinal product is authorised by the licensing authority on a temporary basis in response to the suspected or confirmed spread of—
(a)pathogenic agents;
(b)toxins;
(c)chemical agents; or
(d)nuclear radiation,
which may cause harm to human beings.